Oral versus intravenous proton-pump inhibitors following successful endoscopic treatment in patients with high-risk bleeding peptic ulcers

Trial Profile

Oral versus intravenous proton-pump inhibitors following successful endoscopic treatment in patients with high-risk bleeding peptic ulcers

Completed
Phase of Trial: Phase II

Latest Information Update: 21 May 2011

At a glance

  • Drugs Esomeprazole (Primary) ; Esomeprazole (Primary) ; Lansoprazole
  • Indications Gastrointestinal haemorrhage
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 May 2011 New trial record
    • 10 May 2011 Results presented at Digestive Disease Week 2011.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top